ÖAÖzlem Altındağ

Özlem Altındağ

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Özlem Altındağ has a total of 151 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigation of Serum Nuclear Factor Erythroid 2–Related Factor 2 Levels, Oxidative Stress Parameters, and Thiol-Disulfide Homeostasis in Patients with Fibromyalgia

    by Melike Aşık, Ali Gür, Ozlem Altindag, Mazlum Serdar Akaltun, Elif Balbal

    Background/Aims: In order to delineate the involvement of oxidative stress in fibromyalgia syndrome (FMS), this investigation analyzed systemic biomarkers - including nuclear factor erythroid 2 (Nrf2), total antioxidant status (TAS), total oxidant status (TOS) and thiol-disulfide equilibrium—in female patients with FMS and a reference group of healthy subjects. It was investigated how the patient group’s clinical characteristics, oxidative stress metrics, and Nrf2 levels related to one another. To date, no published studies have assessed serum Nrf2 levels in patients with FMS. Materials and Methods: The study enrolled 50 healthy female participants and 60 FMS patients. Participants were evaluated using the Visual Analog Scale (VAS), Fibromyalgia Impact Questionnaire (FIQ), Beck Depression Scale (BDS), Beck Anxiety Scale (BAS), Pittsburgh Sleep Quality Index (PSQI), Fatigue Severity Scale (FSS), the DN4 Neuropathic Pain Questionnaire, and the count of tender points (TP). Nrf2 level was measured by Enzyme-linked immunosorbent assay method, TAS, TOS, native thiol (NT), total thiol (TT), and disulfide levels were measured by spectrophotometric method. Results: In comparison with the reference group of healthy subjects, patients with FMS displayed significantly elevated values in TP count, FIQ, BDS, BAS, PSQI, FSS, VAS, DN4, TAS, and TOS (P < .001). Conversely, levels of serum Nrf2 were markedly reduced in the FMS group (P < .001). The DN4 scores were negatively and significantly correlated with Nrf2 concentrations (P = .049). Conclusion: The results point to a possible role for Nrf2 in the pathophysiology of FMS and may help identify and treat the condition, especially in individuals with neuropathic pain complaints. These findings are promising, as they indicate that the use of Nrf2 activators may be considered in patients with low Nrf2 levels. The potential utility of Nrf2-activating agents in such subgroups warrants further investigation. Cite this article as: Aşık M, Gur A, Altindag O, Akaltun MS, Balbal E. Investigation of serum nuclear factor erythroid 2–related factor 2 levels, oxidative stress parameters, and thiol-disulfide homeostasis in patients with fibromyalgia. ArchRheumatol. Published online June 3, 2026. doi: 10.5152/ArchRheumatol.2026.25024.

  • Open Access

    Functional and ultrasonographic evaluation of high intensity laser therapy and Kinesio taping in stroke patients with hemiplegic shoulder pain: a randomized controlled trial

    by Mehmet Furkan Oglakci, Ozlem Altindag, Mazlum Serdar Akaltun, Ali Gur

    Hemiplegic shoulder pain (HSP) is a common post-stroke complication that limits functional recovery and rehabilitation participation. The objective of this study was to evaluate and compare the clinical, functional, and ultrasonographic superiority of High-Intensity Laser Therapy (HILT) and Kinesio Taping (KT) over each other, as well as in comparison to conventional therapy (COT). The study was designed as a prospective, double-blind, randomized controlled trial. Participants were allocated into three equal groups (n = 11 each group): Group 1 (Control Group) received COT with sham HILT and sham KT, Group 2 (HILT Group) received COT with active HILT and sham KT, and Group 3 (KT Group) received COT with sham HILT and active KT. COT was performed five days per week for three weeks, HILT was administered in 10 sessions, and KT was applied every other day for three weeks (nine sessions). The primary outcome measure of the study was the Shoulder Pain and Disability Index (SPADI) score. Secondary outcome measures included pain intensity assessed using the Visual Analog Scale (VAS), passive shoulder range of motion (pROM), ultrasonographic findings, Brunnstrom Recovery Stage (BRS), the Functional Independence Measure (FIM), and the Health Assessment Questionnaire (HAQ). All measures were evaluated at baseline (pre-treatment) and immediately following the intervention period (post-treatment). Data were analyzed using repeated measures ANOVA and McNemar tests. Groups were sociodemographically comparable (p > 0.05). Post-treatment, all groups exhibited significant improvements in shoulder flexion, extension, external rotation, and BRS, VAS, SPADI, FIM, and HAQ scores (p < 0.05). No significant changes occurred in ultrasonographic findings, shoulder abduction, or internal rotation. Notably, HILT demonstrated superior VAS and SPADI improvements compared to other groups (p < 0.05). HILT provides rapid, clinically significant pain relief and functional recovery in HSP without adverse effects, offering a safe and superior therapeutic option.

  • Open Access

    Serum prohepcidin levels in patients with rheumatoid arthritis and its relationship with disease activity, treatment, and laboratory parameters

    by Müzeyyen Günay Örkmez, Özlem Altındağ, Mazlum Serdar Akaltun, Ahmet Akyol, Savaş Gürsoy, Ali Gür

    Purpose: This study aimed to compare serum prohepcidin levels in patients with rheumatoid arthritis (RA) and healthy controls, and to evaluate their potential associations with medication use, disease activity, quality of life, and laboratory parameters. Materials and Methods: This cross-sectional study included 59 patients aged 18–75 years diagnosed with RA according to the 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria, along with 64 age- and sex-matched healthy controls. Disease activity was assessed using the Disease Activity Score 28 (DAS28), functional status using the Health Assessment Questionnaire (HAQ), and pain intensity using the Visual Analog Scale (VAS). Serum prohepcidin levels were measured using enzyme-linked immunosorbent assay (ELISA). Laboratory parameters, including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), iron, ferritin, hemoglobin, and transferrin, were extracted from patient records. Results: In the RA group, 80% of patients using TNF inhibitors and 85.3% of those receiving conventional DMARDs (cDMARDs) were female. In the control group, 87.5% were female. Hemoglobin and serum iron levels were significantly higher in the control group compared with both treatment groups. Median transferrin levels were 298.0 g/L in the TNF group, 309.0 g/L in the cDMARD group, and 302.0 g/L in the control group. Median prohepcidin levels were 491.04 pg/mL in the TNF group, 594.27 pg/mL in the cDMARD group, and 534.44 pg/mL in the control group, with no statistically significant differences. Conclusion: Although prohepcidin levels did not differ significantly between RA patients and healthy controls, differences observed in hemoglobin and iron levels may reflect treatment-related alterations in iron metabolism. Further research is needed to elucidate the role of prohepcidin in RA pathophysiology and its potential relationship with disease activity and therapeutic modalities.

  • Reduced forearm muscle thickness and hand strength in patients with rheumatoid arthritis: an ultrasonographic cross-sectional study

    by Can Anil, Mazlum Serdar Akaltun, Ozlem Altindag, Ali Gur

    The aim of this study was to compare forearm muscle thickness measured ultrasonographically in patients with rheumatoid arthritis (RA) with that of a healthy population and to investigate the relationship between this thickness and clinical, sociodemographic, and laboratory data in the patient group. This cross-sectional study included 140 participants: 70 RA patients and 70 healthy controls. Forearm muscle thickness was measured ultrasonographically from the anterior forearm in radial and ulnar regions, and hand grip strength was assessed with a dynamometer. Pain was evaluated using the Visual Analog Scale (VAS), functional status with the Health Assessment Questionnaire (HAQ), hand function with the Duruoz Hand Index (DHI), and disease activity with the Disease Activity Score-28 (DAS28). Results: There were no significant differences in sociodemographic data between the groups (p > 0.05). Ulnar muscle thickness was significantly lower in the RA group than in the control group (3.13 ± 0.37 vs. 3.55 ± 0.33 cm) (p < 0.05). Radial muscle thickness was also reduced in RA patients compared to controls (1.69 ± 0.24 vs. 1.94 ± 0.30 cm) (p < 0.05). Hand grip strength was 20.66 ± 7.78 kg in RA patients and 27.06 ± 9.59 kg in controls. Both measures were negatively correlated with disease duration, HAQ, and DHI (p < 0.05). DAS28 showed a negative correlation with ulnar muscle thickness and handgrip strength (p < 0.05), but not with radial muscle thickness (p > 0.05). These findings demonstrate that forearm muscle thickness is reduced in RA patients and is strongly associated with handgrip strength, disease activity, and functional status. Since decreased muscle mass contributes to loss of hand strength and functional impairment, forearm muscle thickness may represent a valuable parameter for clinicians to consider in the assessment and follow-up of RA patients.


  • Open Access

    Gut Microbiota Mediator Level and Its Relation to Disease Activity in Ankylosing Spondylitis

    by Hasan Nasrallah, Özlem Altındağ, Mazlum Serdar Akaltun, Mehmet Akif Bozdayı, Mustafa Örkmez, Elif Balbal, Ali Gür

    Background/Aims: It is known that the intestinal microbiota plays an essential role in developing many diseases. In this study, the relationship between gut microbiota markers and clinical parameters of ankylosing spondylitis and the effect of drugs on gut microbiota markers were evaluated. The aim of this study is to evaluate the composition of the gut microbiota in individuals with ankylosing spondylitis by comparing it with that of healthy individuals to assess the potential effects of microbial alterations on disease pathogenesis and inflammatory response and to identify differences based on treatment methods. Materials and Methods: This study included 76 AS patients diagnosed for at least 2 years, aged between 18 and 65 (38 anti-TNF recipients and 38 nonsteroidal anti-inflammatory drug [NSAID] recipients), and 38 ageand sex-matched healthy volunteers. Detailed clinical evaluations were conducted on patients and volunteers. All patients underwent a systematic clinical evaluation in accordance with the diagnostic and follow-up criteria for ankylosing spondylitis. In this context, the modified Schober test was performed to assess the lumbar flexion range of motion, chest expansion was measured with a tape measure, and cervical and thoracolumbar spinal range of motion was evaluated using a goniometer. Additionally, a detailed peripheral joint examination, including all major and minor joints, was conducted to identify peripheral joint involvement. Relevant areas were also assessed for the presence of enthesitis in terms of tenderness and pain. Sacroiliac joint tenderness was examined through direct palpation and provocation tests. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured in patients and volunteers, and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) scores were also calculated and recorded in the patient group. CD14, CTLA4, CXC16, lipopolysaccharide (LPS), and TLR4 levels were measured in serum samples using the enzyme-linked immunosorbent assay method. Results: Bath Ankylosing Spondylitis Disease Activity Index and BASFI scores were significantly higher in the NSAI (Non-Steroidal Anti Inflammatory) recipient group than in the anti-TNF recipient group (P < .05). C-reactive protein and ESR levels were significantly lower in patients who received anti-TNF therapy than those who received NSAI therapy (P < .05). CTLA4, CXC16, LPS, and TLR4 levels were found to be significantly higher in patients receiving NSAI treatment compared to those receiving anti-TNF treatment and the healthy controls (P < .05). There were no significant differences between patients and controls concerning CD14 levels (P > .05). Conclusion: This research observed that CRP and ESR levels and disease activity scores in AS patients who received anti-TNF treatment were lower than those in the NSAID treatment group and even closer to the control group. It was believed that the connection between microbiota markers and clinical and inflammatory markers can indicate the pathogenesis of AS, guide treatment follow-up, and help develop new treatment strategies.

  • Open Access

    Comparison of Acute Effects of Classical Massage and Connective Tissue Massage on Lower Extremity Blood Flow Changes

    by İsmail Palalı, Özlem Altındağ

    This study aimed to compare the immediate effects of connective tissue massage and classical massage on lower extremity blood circulation in healthy adults, and to better understand the mechanism of connective tissue massage. Twenty healthy participants underwent a 40-minute classical massage on the left lower limb. One week later, the same individuals received a connective tissue massage. Using color Doppler ultrasound, the diameter, flow velocity, and blood volume of the popliteal and posterior tibial arteries were measured before and after each session. Both massage methods led to significant increases in blood flow velocity, vessel diameter, and blood volume (p<0.05). However, connective tissue massage was more effective than classical massage in increasing the flow velocity and volume in the popliteal artery, as well as the diameter and volume in the posterior tibial artery (p0.05). Overall, while both methods improved circulation, connective tissue massage produced greater improvements in peripheral blood volume, suggesting it may be more beneficial when enhanced vascular response is desired.

  • Open Access

    Investigation of the effectiveness of dry needle therapy in pressure ulcers

    by Mehmet Ergun Kayiran, Ali Cımbız, Uğur Sözlü, Özlem Altındağ

    Aims: This study aims to show whether dry needle therapy is effective in the treatment of pressure ulcers in patients who have developed ulcers anywhere on their body for any reason. Methods: Thirty individuals (16 females, 14 males) with pressure ulcer were included in the study and a total of 6 sessions of dry needle therapy were applied to each individual with a one-day break. Before and after the application, circumference-diameter measurements of the wounds and staging according to the National Pressure Ulcer Advisory Panel scale were made and recorded with photographs. Results: While the average wound diameter before the application was 3.97±2.11, it was determined as 3.21±1.77 after the dry needle treatment (p<0.001). While the wound stage (med[IQR]) before application was 2 [1.75-3], it was determined as 2 [1-3] after application (p: 0.003). Conclusion: Dry needling treatment applied in pressure ulcers was effective in healing the wound and that studies should be conducted on wounds other than pressure sores.

  • Open Access

    Pain types and risk factors in post-COVID-19

    by Ayşegül Ketenci, Mert Zure, Fatma Merih Akpınar, Yelda Soluk Özdemir, Özlem Balbaloğlu, Mazlum Serdar Akaltun, Ender Erden, Ayla Çağlıyan Türk, Merve Damla Korkmaz, Burcu Metin Ökmen, et al.

    Objectives: This study aims to accurately evaluate pain lasting longer than three months and falls under the category of chronic pain and to determine the risk factors to follow up and treat properly and to develop appropriate diagnostic and treatment algorithms. Patients and methods: Between March 2021 and December 2021, a total of 437 patients (162 males, 275 females; mean age: 44±14.6 years; range, 12 to 82 years) who were referred to the participating centers due to pain complaints and were diagnosed with post-COVID-19 condition according to the criteria defined by the World Health Organization (WHO) were included in the study. The patients were divided into three groups as nociceptive pain, neuropathic pain, and central sensitization, based on the physician's clinical evaluation and the Self-Report Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and Central Sensitization Inventory scores. Results: The most common diagnosis was nociceptive pain followed by central sensitization. Patients with nociceptive pain had less pain. It was found that not exercising regularly, having a chronic disease and being a woman were risk factors for central sensitization, having thyroid disease before COVID-19, and defining the current pain as very severe were risk factors for neuropathic pain. Conclusion: In the evaluation of post-COVID-19 pain, neuropathic pain and central sensitization should be also considered in addition to nociceptive pain and the severity of pain, systemic diseases and physical activity should be questioned.


  • WHAT AWAITS US AFTER COVID-19? MUSCULOSKELETAL SYSTEM INVOLVEMENT IN THE ELDERLY POPULATION IN TÜRKİYE AND ITS AFTERMATH

    by Yesim Gokce-Kutsal, Nilufer Kutay Ordu-Gökkaya, Sevilay Karahan, Fatma Jale Irdesel, Nurdan Paker, Saime Ay, Vildan Bi̇nAy-Safer, Dilek Keski̇n, İlKe Coskun Benli̇dAyi̇, Aylin Sari̇, et al.

    Introduction: Although COVID-19 primarily affects the respiratory system, one of the most frequently effected areas is the musculoskeletal system. COVID-19 associated musculoskeletal problems can cause disability in patients ≥65 years. The aim of the study was to define the musculoskeletal problems after the COVID-19 infection and to examine the relationship with the accompanying comorbidities in geriatric population. Materials and Method: The study was conducted by the members of Geriatric Rehabilitation Study Group of Turkish Physical Medicine and Rehabilitation Society at 11 different hospitals from 7 provinces (Ankara, İstanbul, İzmir, Gaziantep, Adana, Bursa, and Kırıkkale) of Türkiye. Individuals aged 65 years and over who had a history of COVID-19 within the last 12 months and experienced persistent/continuous musculoskeletal complaints were included into the study. COVID-19 diagnoses were confirmed from electronic hospital records and the e-Nabız system. Data were collected by face-to-face interviews and after recruiting the first 50 patients from each center, patient recruitment was terminated. Results: A total of 457 cases in which all questions were answered completely (without any missing data) were included in this observational study. The cases were mainly 65-75 years old, married, and non-smoking women. The most common musculoskeletal involvement was widespread pain (81%), followed by myalgia (63.7%) and arthralgia (44.4%). Other rare involvements (osteonecrosis, myositis, steroid myopathy, arthritis) were significantly more frequent in patients older than 75 years, regardless of gender. Analysis showed that musculoskeletal pain immediately after infection is observed more in cases with comorbid diseases (p<0.001), hypertension (p<0.001), pulmonary involvement (p=0.002) and hospitalization due to COVID-19 (p<0.001). It was determined that the incidence of pain seen immediately after infection increased as the number of comorbidities increased (p<0.001). In conjunction with this, persistent pain after COVID-19 infection were more common in those with osteoarthritis (p=0.039). Conclusion: Elderly patients may develop musculoskeletal pain in multiple body sites after COVID-19, which is primarily related to presence and number of comorbidities, hospitalization and pulmonary involvement. The long-term consequences of COVID-19 on musculoskeletal health are still being studied, and further research is needed to fully understand the extent and duration of these effects. Keywords: Aged; COVID-19; Arthralgia; Musculoskeletal Pain.


  • Open Access

    Effectiveness of kinesiotape and sham kinesiotape application in children with cerebral palsy with dysphagia: A randomized controlled study

    by Mazlum Serdar Akaltun, Ebru Umay, Ozlem Altindag, Ozgur Zeliha Karaahmet

    Objectives: The aim of this study was to evaluate the effects of low-level laser therapy (LLLT) and therapeutic ultrasound (US) combined with home-based exercise (HBE) versus HBE alone in patients with subacromial impingement syndrome (SAIS). Patients and methods: Between March 2021 and July 2021, a total of 60 patients with SAIS (19 males, 41 females; mean age: 51.3±10.4 years; range, 30 to 70 years) were included. The patients were randomly allocated to an LLLT group (LG), an US therapy group (UG), and a control group (CG). The LLLT and US therapy programs were applied five times a week, for a total of 15 sessions. Home-based exercise programs and cold-pack therapy were administered to patients in each group. The patients were evaluated at baseline and one and three months of follow-up using the Visual Analog Scale (VAS) for pain during activity, at rest, and at night, and the Shoulder Pain and Disability Index (SPADI). Results: All groups showed a significant improvement in the VAS and SPADI scores after the first month (p0.05). Conclusion: The LLLT combined with HBE is more effective than HBE program alone for relieving activity pain and improving shoulder functions in the short term. However, LLLT and US therapy do not provide additional effects in terms of pain and disability at three months.